Cristina Di Poto

Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis

Habtom W. Ressom, Jun Xiao, Leepika Tuli et al. · Analytica Chimica Acta · 2012 · 159 citations · Full text

Hepatology, Liver Physiology, Liver Cirrhosis +12

LC–MS Based Serum Metabolomics for Identification of Hepatocellular Carcinoma Biomarkers in Egyptian Cohort

Jun Xiao, Rency S. Varghese, Bin Zhou et al. · Journal of Proteome Research · 2012 · 129 citations · Full text

YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells

Shannon M. White, Maria Laura Avantaggiati, Ivan Nemazanyy et al. · Developmental Cell · 2019 · 112 citations · Full text

Tumor Biology, Nf2-deficient Tumor Cells, Signal Transduction +11

Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma

Alessia Ferrarini, Cristina Di Poto, Shisi He et al. · Journal of Proteome Research · 2019 · 87 citations · Full text

Metabolomic Profiling, Pathology, Hcc Pathogenesis +18

GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort

Mohammad Ranjbar, Yue Luo, Cristina Di Poto et al. · PLoS ONE · 2015 · 83 citations · Full text

Bcaa Supplementation, Plasma Metabolomics, Metabolomic Profiling +19